Tirzepatide, TR, purity 99%, Free Sample Available various peptides, available in stock peptides, global distribution, factory direct supply
TDS 275 Inquiries
2023788-19-2
Industrial Grade
99%
shenzhen
subi
5/10/15/20/30/40/50/60mg*10vials
Yes
2028-08-18
peptone
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptone
-
Location:
Room A109, No. 29 Dongting Road, Hexi District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
3 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2024
-
-
Inquiry History275 Inquiries
Country Product Purchase Quantity Date Posted
Germany
2023788-19-2
1 MG Jun 18, 2026
Poland
TIRZEPATIDE
10 MG Feb 18, 2026
United Kingdom
tirzepatide
10 MG Oct 21, 2025
Poland
Tirzepatide
30 MG Jun 15, 2026
Philippines
Tirzepatide
20 MG Sep 28, 2026
United States
Tirzepatide
30 MG Sep 22, 2026
United States
Tirzepatide
30 MG Sep 14, 2026
United States
tirzepatide
12 MG Sep 8, 2026
United Kingdom
Tirzepatide
20 MG Sep 8, 2026
Philippines
Tirzepatide
30 MG Sep 3, 2026
Philippines
Tirzepatide
40 MG Aug 24, 2026
United States
Tirzepatide
30 MG Aug 17, 2026
United States
Tirzepatide
10 MG Aug 10, 2026
United States
Tirzepatide
20 MG Aug 4, 2026
United States
Tirzepatide
30 MG Jul 31, 2026
United States
Tirzepatide
10 MG Jul 28, 2026
United States
Tirzepatide
40 MG Jul 28, 2026
Brazil
Tirzepatide
5 MG Jul 16, 2026
United States
Tirzepatide
15 MG Jul 14, 2026
United States
Tirzepatide
10 MG Jul 13, 2026 Post an enquiry for this product
More from this Seller
-
-
-
High purity 2-Bromo-9,9-diethylfluorene human with Safe Delivery
Industrial Grade / 99%
-
-
-
-
Slimming Peptide Weight Loss Peptide Powder Semaglutide Kits
Industrial Grade / 99%
-
-
-
-
China Most Professional Factory Supply Hot Sale High Qulity Oleic acid
Industrial Grade / 99%
-
-
-
-
AEF0117 factory direct wholesale white raw powder high quality
Industrial Grade / 99%
-
-
-
-
Retatrutide 10mg white raw powder lipid-lowering lose weight
Industrial Grade / 99%
-